Have a personal or library account? Click to login
Current Therapeutic Options in Active Moderate-to-Severe Thyroid-Associated Ophthalmopathy Cover

Current Therapeutic Options in Active Moderate-to-Severe Thyroid-Associated Ophthalmopathy

Acta Medica Bulgarica
Volume 50 (2023): Issue 4 (December 2023)
By: M. Stoynova,  A. Shinkov and  R. Kovatcheva  
Open Access
|Dec 2023

Authors

M. Stoynova

mariya.stoynova@abv.bg

Department of Endocrinology, Medical University, Sofia, Bulgaria

A. Shinkov

Department of Endocrinology, Medical University, Sofia, Bulgaria

R. Kovatcheva

Department of Endocrinology, Medical University, Sofia, Bulgaria
DOI: https://doi.org/10.2478/amb-2023-0045 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Journal RSS Feed
Language: English
Page range: 59 - 68
Submitted on: Jan 28, 2023
Accepted on: Jun 13, 2023
Published on: Dec 15, 2023
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
thyroid-associated opthalmopathy,
treatment,
glucocorticoids,
therapeutic response
Related subjects:
Medicine,
Basic medical science,
Immunology,
Clinical medicine,
Clinical medicine, other

© 2023 M. Stoynova, A. Shinkov, R. Kovatcheva, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 50 (2023): Issue 4 (December 2023)Next article